Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05882812 · ClinicalTrials.gov registry record · Phase 2
Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Knee Pain Related to Osteoarthritis
A Phase 2 study of Arthritis and Osteo Arthritis Knee, sponsored by ZetrOZ.
- Completed
- Registry status
- Phase 2
- Development phase
- 200
- Enrollment target
- 3
- Study locations
NCT05882812 is a Phase 2 study of Arthritis and Osteo Arthritis Knee that has completed, run by ZetrOZ. The registered enrollment target is 200 participants, below the 4,506-participant average among 48 other Arthritis trials with a reported enrollment target (96% lower). The trial reports 3 study locations across 2 states.
The verdict
NCT05882812, a Phase 2 study of Arthritis and Osteo Arthritis Knee, has completed, sponsored by ZetrOZ.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 200 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to assess the ability of long-duration low-intensity therapeutic ultrasound (LITUS) to alleviate knee Osteoarthritis pain over an 8-week period. The primary objective of this study is to evaluate the analgesic effect of LITUS in subjects suffering from knee Osteoarthritis pain. Secondary objectives are to assess the ability of LITUS to improve joint function.
Conditions Studied
Interventions
- DEVICE Sustained Acoustic Device with 2.5% Diclofenac Patch
- DRUG 2.5% Diclofenac Patches
- DEVICE Sustained Acoustic Device with 0% Diclofenac Patch
Study Locations (3)
Connecticut
- Orthopaedic Foundation - Stamford
- ZetrOZ Systems - Trumbull
New York
- Cayuga Medical Center - Medical Pain Consultants - Dryden
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2023-06-03 |
| Est. Completion | 2024-02-22 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05882812
The ClinicalTrials.gov registry entry for NCT05882812 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,506-participant average among 48 other Arthritis trials with a reported enrollment target (96% lower). The listed sponsor is ZetrOZ, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Arthritis appearing as the primary indexed condition, and to 3 interventions - of which Sustained Acoustic Device with 2.5% Diclofenac Patch is the first listed.
NCT05882812 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Connecticut, New York.
Frequently Asked Questions
What is clinical trial NCT05882812 about?
NCT05882812 is a clinical study titled "Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Knee Pain Related to Osteoarthritis". The purpose of this study is to assess the ability of long-duration low-intensity therapeutic ultrasound (LITUS) to alleviate knee Osteoarthritis pain over an 8-week period. The primary objective of this study is to evaluate the analgesic effect of LITUS in subjects suffering from knee Osteoarthriti...
What is the current status of trial NCT05882812?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 2023-06-03. Estimated completion is 2024-02-22.
What conditions does trial NCT05882812 study?
This clinical trial studies the following conditions: Arthritis, Osteo Arthritis Knee.
What interventions are being tested in trial NCT05882812?
The interventions under investigation include: Sustained Acoustic Device with 2.5% Diclofenac Patch (DEVICE), 2.5% Diclofenac Patches (DRUG), Sustained Acoustic Device with 0% Diclofenac Patch (DEVICE).
Who is sponsoring clinical trial NCT05882812?
This trial is sponsored by ZetrOZ, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05882812 being conducted?
This trial has 3 study locations across Connecticut, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ultralow Dose PET Imaging for 18F-NaF Uptake
RECRUITING · Phase 2
-
Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare
RECRUITING · Phase 2
-
Sustained Acoustic Medicine for Symptomatic Treatment of Knee Pain Related to Osteoarthritis
RECRUITING · Phase 2
-
Fitness and Exercise for People With Arthritis
COMPLETED · Phase 2
-
A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal Insufficiency
COMPLETED · Phase 2
-
A Qualitative Assessment of the Severity and Impact of Rheumatic Immune-Related Adverse Events Following Immune Checkpoint Inhibitor Immunotherapy
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.